首页 > 专利信息

MOBILE COMMUNICATION SYSTEM, BASE STATION AND COMMUNICATION CONTROL METHOD

申请公布号:EP2945448(A1)

申请号:EP20150168501

申请日期:2013.01.18

申请公布日期:2015.11.18

申请人:
KYOCERA CORPORATION

发明人:MORITA, KUGO;YAMAZAKI, CHIHARU

分类号:H04W72/04

主分类号:H04W72/04

摘要:<p>In a mobile communication system in which a plurality of base stations included in a CoMP cooperating set allocate a same communication resource to a user terminal to perform a communication, each of the plurality of base stations comprises a notification unit that notifies another base station included in the CoMP cooperating set of a communication resource of allocation candidate for the user terminal in the base station itself; a receiver that receives a notification of a communication resource of allocation candidate for the user terminal in another base station included in the CoMP cooperating set from the other base station; and a disabling unit that performs setting to disable allocation of a communication resource of allocation candidate, depending on a reception state of the receiver.</p>

专利推荐

Golf club loft and lie instructional tool

Piano

Refrigerator

Field for control panel of road construction machine

Agricultural machine

Display screen with icon

Portion of a display panel with a graphical user interface

Display screen or portion thereof with icon

Data communications performance monitoring

Therapeutic methods and compositions

Contracting and elongating materials for providing input and output for an electronic device

SYSTEMS AND METHODS FOR IDENTIFYING AND SUGGESTING EMOTICONS

Circuitry for charging a depleted battery in an implantable medical device without passive trickle charging

Access chamber and markers for biopsy device

SYSTEMS AND METHODS FOR REGENERATIVE DYNAMIC BRAKING

Multi-transgenic pigs for diabetes treatment

Novel parasite therapy

AN ELECTROSURGICAL SYSTEM AND GENERATOR

Image decoding method, image coding method, image decoding apparatus, image coding apparatus, and image coding and decoding apparatus

Methods of treatment using selective Bcl-2 inhibitors